Creating an effective program within your facility requires adequate supplies to respond to emergencies and personnel properly trained in performing basic first aid.
70 is the new 40. Ringo Starr celebrated his 70th birthday with a gig at Radio City Music Hall in New York City this summer. Also 70 this year: Al Pacino, Chuck Norris and Raquel Welch.
After the first several weeks of uncertainty, most of the news about the 2009 H1N1 "swine flu" pandemic has been reassuring, according to the Harvard Health Letter, December, 2009 edition.
Every winter, millions of people catch influenza "a viral infection of the airways”and about half a million people die as a result. In the U.S. alone, an average of 36,000 people are thought to die from influenza-related causes every year.
Through November, 2009, approximately 99% of typed influenza viruses have been 2009 H1N1. The vast majority of 2009 H1N1 viruses tested for drug resistance have been susceptible to oseltamivir and zanamivir but resistant to the adamantanes (amantadine, rimantadine). Surveillance data, updated weekly, are available at www.cdc.gov/flu/weekly These recommendations will be revised as needed to adapt to new information on risk factors, antiviral availability and resistance, or the circulation of other influenza viruses.
The Centers for Disease Control and Prevention (CDC) developed a method to provide an estimated range of the total number of 2009 H1N1 cases, hospitalizations and deaths in the United States by age group using data on flu associated hospitalizations collected through CDC’s Emerging Infections Program. On November 12, 2009 CDC provided the first estimates for April through October 17, 2009 and committed to updating those estimates approximately monthly.
The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.
RSS